NCT00001287View on ClinicalTrials.gov

Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 1990

Study Completion Date

January 31, 2001

Conditions
Demyelinating DiseasesParaproteinemias
Interventions
DRUG

intravenous immunoglobulin (IVIg)

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH